Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 198 clinical trials
Featured trial
Re-assessment of diagnostic cortisol values for adrenal insufficiency using a highly specific cortisol assay

that have specific functions in the body. One of these hormones is cortisol. Among other functions, cortisol in the blood helps to keep blood pressure and blood sugars normal. Cortisol is also important

Accepts healthy volunteers
  • 0 views
  • 08 Jan, 2022
  • 1 location
Featured trial
Type 2 Diabetes Study – Seeking Volunteers Who Treat with Any Combination of Medications, Except Insulin.

them. Participants will continue taking their other diabetes medications. Participants must be willing to check their blood sugars at least once a day.  Also, they must

  • 46 views
  • 08 Oct, 2021
  • 1 location
Featured trial
A Randomized Phase 3 Study of Sitravatinib in Combination with Nivolumab Versus Docetaxel in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer with Disease Progression On or After Platinum-Based Chemotherapy and Checkpoint Inhibitor Therapy (SAPPHIRE)

This is an open-label, randomized (1:1), multicenter, Phase 3 clinical trial evaluating the safety and efficacy of nivolumab in combination with investigational agent sitravatinib compared to docetaxel in patients with advanced non-squamous NSCLC who have previously experienced radiographic disease progression on or after treatment with platinum-based chemotherapy in combination with …

cancer
docetaxel
non-squamous non-small cell lung cancer
squamous non-small cell lung cancer
advanced non-squamous non-small cell lung cancer
  • 417 views
  • 14 Jan, 2022
  • 216 locations
Featured trial
Weekly Basal Insulin - Allowing More Flexibility With Treating Type 1 Diabetes. (In the Greater Seattle Area.)

>Participants must be willing to check their blood sugars 4 times a day and record the data using an electronic-diary (cannot use CGM values). Participants must be willing to wear a Dexcom G6 continuous glucose

hemoglobin a1c
Accepts healthy volunteers
sugars
insulin
  • 18 views
  • 08 Oct, 2021
  • 1 location
Featured trial
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of LX-4211 as Adjunct Therapy in Adult Patients with Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control

A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of LX-4211 as Adjunct Therapy in Adult Patients with Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control

  • 934 views
  • 23 Nov, 2020
  • 1 location
Featured trial
Uncontrolled Blood Sugar? Take Control. Let us Help.

Uncontrolled Blood Sugar? Take Control. Let us Help.

  • 46 views
  • 08 Nov, 2020
  • 1 location
Featured trial
The INSTRIDE 2 Study is looking to see how well an investigational insulin works to control blood sugar levels in patients with Type 2 Diabetes.

The INSTRIDE 2 Study is looking to see how well an investigational insulin works to control blood sugar levels in patients with Type 2 Diabetes.

  • 199 views
  • 23 Nov, 2020
  • 1 location
Featured trial
The INSTRIDE 1 Study is looking to see how well an investigational insulin works to control blood sugar levels in patients with Type 1 Diabetes.

The INSTRIDE 1 Study is looking to see how well an investigational insulin works to control blood sugar levels in patients with Type 1 Diabetes.

  • 457 views
  • 23 Nov, 2020
  • 1 location
Featured trial
A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients With Advanced Solid Tumors With KRAS G12C Mutation

Evaluates the safety, tolerability, pharmacokinetics, metabolites, pharmacodynamics, and clinical activity of MRTX849 in patients with advanced solid tumors with a KRAS G12C mutation. MRTX849 is an orally-available small molecule inhibitor of KRAS G12C.

advanced solid tumor
solid tumor
malignant solid tumor
  • 536 views
  • 22 Nov, 2021
  • 72 locations
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA Vaccine Against Influenza

This is a Phase 1 randomized study to evaluate the safety and immunogenicity of monovalent influenza modRNA vaccine (mIRV) and bivalent influenza modRNA vaccine (bIRV) at various dose levels, and quadrivalent influenza modRNA vaccine (qIRV), in participants 65 to 85 years of age. Participants will receive at Vaccination 1 either: …

quadrivalent inactivated influenza vaccine
Accepts healthy volunteers
trivalent influenza vaccine
strain
  • 0 views
  • 15 Jan, 2022
  • 42 locations